E Shyong Tai
Genetics & Molecular Biology
Genome Institute of Singapore
Singapore
Biography
Dr Tai’s has a longstanding interest in the development of novel treatments for diabetes mellitus that leverages on human genetics for the identification of novel drug targets. More recently, he has begun working on better ways to implement existing treatments into clinical practise to optimize cost effectiveness. One approach involves the stratification of patients based on level of risk of adverse outcomes or responsiveness to specific therapies. Another involves the implementation of novel models of care for chronic disease including (but not limited to) primary care enhancement by implementing the principles of the patient centred medical home.
Research Interest
Human Genetics
